Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,159
Closed -$230K 411
2020
Q2
$230K Hold
1,159
0.04% 352
2020
Q1
$212K Buy
+1,159
New +$206K 0.05% 330
2019
Q2
Sell
-1,790
Closed -$220K 344
2019
Q1
$220K Sell
1,790
-35
-2% -$4.39K 0.04% 307
2018
Q4
$213K Buy
1,825
+8
+0.4% +$943 0.05% 290
2018
Q3
$227K Sell
1,817
-778
-30% -$85.9K 0.04% 343
2018
Q2
$221K Buy
+2,595
New +$191K 0.05% 324

Other funds holding AMED

IFG Advisory's AMED Position: Q3 2020 in Review

IFG Advisory sold out of Amedisys (AMED) in Q3 2020, closing a stake of 1,159 shares — an estimated $230K sold.

IFG Advisory first reported a position in AMED in Q2 2018 and held it in 6 quarters. The position peaked at $230K in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • IFG Advisory reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
  • IFG Advisory sold 1,159 Amedisys shares in Q3 2020, an estimated $230K.
  • IFG Advisory first reported a position in Amedisys in Q2 2018 and held it in 6 quarters.
  • IFG Advisory's Amedisys position peaked at $230K in Q2 2020.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on IFG Advisory's 13F filing for Q3 2020, filed 2 Nov 2020.